Open AccessSevere Type of Erythema Multiforme (EM major) due to Administration of Anti-PD-1 Antibody Drug
Author(s) -
Shoya Yano,
Aika Okuno,
Fukumi Furukawa
Publication year - 2021
Publication title -
trends in immunotherapy
Language(s) - English
Resource type - Journals
ISSN - 2573-5985
DOI - 10.24294/ti.v5.i1.1247
Subject(s) - toxic epidermal necrolysis , erythema multiforme , discontinuation , medicine , dermatology , drug , erythema , pharmacology
Immune checkpoint inhibitors can sometimes cause unexpected skin side effects. Special attention should be paid to a severe form of erythema multiforme (EM), toxic epidermal necrolysis and Stevens-Johnson syndrome. We experienced a patient who took 10 weeks from drug discontinuation to the onset of EM major.